Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vivity Outcomes in Patients With Early Stage Glaucoma

NCT04670575 is registered in ClinicalTrials.gov with Vance Thompson Vision as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04670575 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vivity Outcomes in Patients With Early Stage Glaucoma
Lead sponsor
Vance Thompson Vision
Phase
Observational
Overall status
Completed
Start date
January 1, 2021
Completion date
November 30, 2022
Enrollment
27 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.